Long-term management of alcoholic liver disease

Clinics in Liver Disease

Volumn 9, Issue 1, 2005, Pages 135-149

  Wakim Fleming, Jamilé ^a   Mullen, Kevin D ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANABOLIC AGENT; ANDROGEN; ANESTHETIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; CHORIONIC GONADOTROPIN; CLOMIFENE; COLCHICINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; LACTULOSE; MIDODRINE; NADOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENTOXIFYLLINE; PROPYLTHIOURACIL; PROSTACYCLIN; S ADENOSYLMETHIONINE; SILYMARIN; SPIRONOLACTONE; TERLIPRESSIN; URSODEOXYCHOLIC ACID;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ANEMIA; ASCITES; BACTERIAL PERITONITIS; CLINICAL TRIAL; ESOPHAGUS VARICES; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; HYPOPROTHROMBINEMIA; IMMUNITY; IMPOTENCE; NUTRITION; OSTEODYSTROPHY; PULMONARY HYPERTENSION; REVIEW; SIDE EFFECT; SURGICAL RISK; VIRUS INFECTION;

EID: 14844337493     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2004.10.001     Document Type: Review

References (93)

1. J.J. Maher Alcoholic liver disease M. Feldman M. Sleisenger J. Fordtran Gastrointestinal and liver disease 2002 Elsevier Philadelphia 1375 1391
2. M. Ramstedt Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries Addiction 96 Suppl 1 2001 S19 S33
3. U.A. Marbet, L. Bianchi, and U. Meury Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease J Hepatol 4 3 1987 364 372
4. A. Pares, J. Caballeria, and M. Bruguera Histological course of alcoholic hepatitis. influence of abstinence, sex and extent of hepatic damage J Hepatol 2 1 1986 33 42
5. H. Moshage Alcoholic liver disease: a matter of hormones? J Hepatol 35 1 2001 130 133
6. U. Becker, A. Deis, and T.I. Sorensen Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study Hepatology 23 5 1996 1025 1029
7. 10th special report to the US Congress on alcohol and health: highlights from current research from the Secretary of Health and Human Services. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. NIH publication no. 00-1583. Bethesda (MD): National Institutes of Health; 2000. p. 429-30
8. A.J. McCullough, and J.F. O'Connor Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology Am J Gastroenterol 93 11 1998 2022 2036
9. S.L. Friedman Liver fibrosis-from bench to bedside J Hepatol 38 Suppl 1 2003 S38 S53
10. V.J. Desmet, and T. Roskams Cirrhosis reversal: a duel between dogma and myth J Hepatol 40 5 2004 860 867
11. B. Raynard, A. Balian, and D. Fallik Risk factors of fibrosis in alcohol-induced liver disease Hepatology 35 3 2002 635 638
12. A.S. Tavill, and A.M. Qadri Alcohol and iron Semin Liver Dis 24 3 2004 317 325
13. F. Stickel, D. Schuppan, and E.G. Hahn Cocarcinogenic effects of alcohol in hepatocarcinogenesis Gut 51 1 2002 132 139
14. R.M. Kadden Project MATCH: treatment main effects and matching results Alcohol Clin Exp Res 20 8 Suppl 1996 196A 197A
15. M.F. Fleming, M.P. Mundt, and M.T. French Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings Med Care 38 1 2000 7 18
16. A.I. Wilk, N.M. Jensen, and T.C. Havighurst Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers J Gen Intern Med 12 5 1997 274 283
17. N.D. Grace, R.J. Groszmann, and G. Garcia-Tsao Portal hypertension and variceal bleeding: an AASLD single topic symposium Hepatology 28 3 1998 868 880
18. C. Merkel, R. Marin, and P. Angeli A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis Gastroenterology 127 2 2004 476 484
19. L.A. Baker, C. Smith, and G. Lieberman The natural history of esophageal varices; a study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding Am J Med 26 2 1959 228 237
20. A.E. Dagradi The natural history of esophageal varices in patients with alcoholic liver cirrhosis. An endoscopic and clinical study Am J Gastroenterol 57 6 1972 520 540
21. R. de Franchis, and M. Primignani Why do varices bleed? Gastroenterol Clin North Am 21 1 1992 85 101
22. J. Vorobioff, R.J. Groszmann, and E. Picabea Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study Gastroenterology 111 3 1996 701 709
23. B.A. Runyon Management of adult patients with ascites due to cirrhosis Hepatology 39 3 2004 841 856
24. F. Michot, and J. Gut Alcohol-induced bone marrow damage. A bone marrow study in alcohol-dependent individuals Acta Haematol 78 4 1987 252 257
25. J.N. Batista, F. Santolaria, and E. Gonzalez-Reimers Evaluation of marrow cellularity in alcoholism and hepatic cirrhosis, by aspiration, biopsy and histomorphometric Drug Alcohol Depend 22 1-2 1988 27 31
26. F.H. Wezeman, and Z. Gong Adipogenic effect of alcohol on human bone marrow-derived mesenchymal stem cells Alcohol Clin Exp Res 28 7 2004 1091 1101
27. C.S. Lieber Hepatic, metabolic and toxic effects of ethanol: 1991 update Alcohol Clin Exp Res 15 4 1991 573 592
28. C.S. Lieber Alcoholic liver injury: pathogenesis and therapy in 2001 Pathol Biol [Paris] 49 9 2001 738 752
29. K.G. Ishak, H.J. Zimmerman, and M.B. Ray Alcoholic liver disease: pathologic, pathogenetic and clinical aspects Alcohol Clin Exp Res 15 1 1991 45 66
30. P. Malik, D. Bogetti, and P. Sileri Spur cell anemia in alcoholic cirrhosis: cure by orthotopic liver transplantation and recurrence after liver graft failure Int Surg 87 4 2002 201 204
31. K. Watt, J. Uhanova, and G.Y. Minuk Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center Am J Gastroenterol 97 8 2002 2046 2050
32. A. Cardenas, and V. Arroyo Hepatorenal syndrome Ann Hepatol 2 1 2003 23 29
33. P. Gines, M. Guevara, and V. Arroyo Hepatorenal syndrome Lancet 362 9398 2003 1819 1827
34. P. Sort, M. Navasa, and V. Arroyo Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 6 1999 403 409
35. Z. Gong, and F.H. Wezeman Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells Alcohol Clin Exp Res 28 3 2004 468 479
36. C.M. Schnitzler, W.M. Pieczkowski, and V. Fredlund Histomorphometric analysis of osteopenia associated with endemic osteoarthritis [Mseleni joint disease] Bone 9 1 1988 21 27
37. D.D. Bikle, A. Stesin, and B. Halloran Alcohol-induced bone disease: relationship to age and parathyroid hormone levels Alcohol Clin Exp Res 17 3 1993 690 695
38. P. Peris, A. Pares, and N. Guanabens Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics Alcohol Alcohol 27 6 1992 619 625
39. American Gastroenterological Association medical position statement Osteoporosis in hepatic disorders Gastroenterology 125 3 2003 937 940
40. W.D. Leslie, C.N. Bernstein, and M.S. Leboff AGA technical review on osteoporosis in hepatic disorders Gastroenterology 125 3 2003 941 966
41. M.B. Fallon, and G.A. Abrams Hepatopulmonary syndrome Curr Gastroenterol Rep 2 1 2000 40 45
42. C.M. Cornely, R.R. Schade, and D.H. Van Thiel Chronic advanced liver disease and impotence: cause and effect? Hepatology 4 6 1984 1227 1230
43. W.E. Farnsworth, A.H. Cavanaugh, and J.R. Brown Factors underlying infertility in the alcoholic Arch Androl 1 2 1978 193 195
44. W. Van Steenbergen Alcohol, liver cirrhosis and disorders in sex hormone metabolism Acta Clin Belg 48 4 1993 269 283
45. D.H. Van Thiel, J.S. Gavaler, and A. Sanghvi Recovery of sexual function in abstinent alcoholic men Gastroenterology 84 4 1983 677 682
46. N.N. Zein, A.S. Abdulkarim, and R.H. Wiesner Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease J Hepatol 32 2 2000 209 217
47. A.T. Blei, and J. Cordoba Hepatic encephalopathy Am J Gastroenterol 96 7 2001 1968 1976
48. K.D. Mullen Newer aspects of hepatic encephalopathy Indian J Gastroenterol 22 Suppl 2 2003 S17 S20
49. K.D. Mullen Interplay of portal pressure, portal perfusion and hepatic arterial inflow in modulating expression of hepatic encephalopathy in patients with spontaneous or artificially created portosystemic shunts Indian J Gastroenterol 22 Suppl 2 2003 S25 S27
50. V. Siegerstetter, and M. Rossle The role of TIPS for the treatment of portal hypertension: effects and efficacy Acta Gastroenterol Belg 60 3 1997 233 237
51. C. Bureau, J.C. Garcia-Pagan, and P. Otal Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study Gastroenterology 126 2 2004 469 475
52. M. Rossle, and K.D. Mullen Long-term patency is expected with covered TIPS stents: this effect may not always be desirable! Hepatology 40 2 2004 495 497
53. S. Morikawa, K. Kumada, and K. Fukui Closure of interposition mesocaval shunt in a case of idiopathic portal hypertension Am J Gastroenterol 84 5 1989 548 551
54. P. Ferenci, A. Lockwood, and K. Mullen Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998 Hepatology 35 3 2002 716 721
55. M.R. Arguedas, T.G. DeLawrence, and B.M. McGuire Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis Dig Dis Sci 48 8 2003 1622 1626
56. A. Srivastava, R. Mehta, and S.P. Rothke Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance J Hepatol 21 6 1994 1023 1028
57. C. Wein, H. Koch, and B. Popp Minimal hepatic encephalopathy impairs fitness to drive Hepatology 39 3 2004 739 745
58. M. McCrea, J. Cordoba, and G. Vessey Neuropsychological characterization and detection of subclinical hepatic encephalopathy Arch Neurol 53 8 1996 758 763
59. J. Cordoba, J. Lopez-Hellin, and M. Planas Normal protein diet for episodic hepatic encephalopathy: results of a randomized study J Hepatol 41 1 2004 38 43
60. K.D. Mullen, and S. Dasarathy Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma? J Hepatol 41 1 2004 Jul 147 148
61. F. Stickel, B. Hoehn, and D. Schuppan Review article: nutritional therapy in alcoholic liver disease Aliment Pharmacol Ther 18 4 2003 357 373
62. N. Srivastava, N. Singh, and Y.K. Joshi Nutrition in the management of hepatic encephalopathy Trop Gastroenterol 24 2 2003 59 62
63. C. Zavaglia, M. Brivio, and E. Losacco The dietary protein contribution and hepatic encephalopathy in cirrhosis [Italian] Recenti Prog Med 83 4 1992 218 223
64. G. Pelletier, D. Roulot, and T. Davion A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice Hepatology 37 4 2003 887 892
65. A. Rambaldi, G. Iaquinto, and C. Gluud Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review Am J Gastroenterol 97 7 2002 1674 1681
66. A. Rambaldi, and C. Gluud Propylthiouracil for alcoholic liver disease Cochrane Database Syst Rev 2 2002 CD002800
67. H. Cortez-Pinto, P. Alexandrino, and M.E. Camilo Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial Eur J Gastroenterol Hepatol 14 4 2002 377 381
68. A. Rambaldi, and C. Gluud Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis Cochrane Database Syst Rev 3 2001 CD002148
69. P. Ferenci, B. Dragosics, and H. Dittrich Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver J Hepatol 9 1 1989 105 113
70. K. Wellington, and B. Jarvis Silymarin: a review of its clinical properties in the management of hepatic disorders BioDrugs 15 7 2001 465 489
71. A. Pares, R. Planas, and M. Torres Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial J Hepatol 28 4 1998 615 621
72. C.S. Lieber S-adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings Alcohol 27 3 2002 173 177
73. A. Rambaldi, and C. Gluud S-adenosyl-L-methionine for alcoholic liver diseases Cochrane Database Syst Rev 4 2001 CD002235
74. B. Campillo, J.P. Richardet, and E. Scherman Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study Nutrition 19 6 2003 515 521
75. P. Tessari Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils Curr Opin Clin Nutr Metab Care 6 1 2003 79 85
76. H. Andersen, M. Borre, and J. Jakobsen Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy Hepatology 27 5 1998 1200 1206
77. M.J. Muller Malnutrition in cirrhosis J Hepatol 23 Suppl 1 1995 31 35
78. D. Franco, J. Belghiti, and A. Cortesse Nutritional status and immunity in alcoholic cirrhosis (author's transl) Gastroenterol Clin Biol 5 10 1981 839 846
79. C.L. Mendenhall, S. Anderson, and R.E. Weesner Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis Am J Med 76 2 1984 211 222
80. E.J. Kovacs Influence of alcohol and gender on immune response. National Institute on Alcohol Abuse and Alcoholism Available at: www.niaaa.nih.gov/ publications Accessed 2002
81. S. Hirsch, M.P. de la Maza, and V. Gattas Nutritional support in alcoholic cirrhotic patients improves host defenses J Am Coll Nutr 18 5 1999 434 441
82. N.K. Aagaard, H. Andersen, and H. Vilstrup Muscle strength, Na,K-pumps, magnesium and potassium in patients with alcoholic liver cirrhosis-relation to spironolactone J Intern Med 252 1 2002 56 63
83. J.F. Westphal, and J.M. Brogard Drug administration in chronic liver disease Drug Saf 17 1 1997 47 73
84. N. Chalasani, A. Said, and R. Ness Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey Am J Gastroenterol 94 8 1999 2224 2229
85. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 3 2001 421 430
86. National Institutes of Health Consensus Development Conference Panel statement Management of hepatitis C Hepatology 26 3 Suppl 1 1997 2S 10S
87. T.E. Starzl, D. Van Thiel, and A.G. Tzakis Orthotopic liver transplantation for alcoholic cirrhosis JAMA 260 17 1988 2542 2544
88. S. Tome, C. Martinez-Rey, and A. Gonzalez-Quintela Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease J Hepatol 36 6 2002 793 798
89. G.P. Pageaux, P. Perney, and D. Larrey Liver transplantation for alcoholic liver disease Addict Biol 6 4 2001 301 308
90. W.R. Yates, M. Martin, and D. LaBrecque A model to examine the validity of the 6-month abstinence criterion for liver transplantation Alcohol Clin Exp Res 22 2 1998 513 517
91. S. Jauhar, J.A. Talwalkar, and T. Schneekloth Analysis of factors that predict alcohol relapse following liver transplantation Liver Transplant 10 3 2004 408 411
92. S. Tome, and M.R. Lucey Timing of liver transplantation in alcoholic cirrhosis J Hepatol 39 3 2003 302 307
93. J. Neuberger, K.H. Schulz, and C. Day Transplantation for alcoholic liver disease J Hepatol 36 1 2002 130 137